Skip to main content
Journal cover image

The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy.

Publication ,  Journal Article
Gurbel, PA; Navarese, EP; Tantry, US
Published in: Eur Heart J
August 1, 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

August 1, 2019

Volume

40

Issue

29

Start / End Page

2441 / 2443

Location

England

Related Subject Headings

  • Ticagrelor
  • Myocardial Infarction
  • Humans
  • Fibrinolytic Agents
  • Coronary Artery Bypass
  • Cardiovascular System & Hematology
  • Aspirin
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., Navarese, E. P., & Tantry, U. S. (2019). The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy. Eur Heart J, 40(29), 2441–2443. https://doi.org/10.1093/eurheartj/ehz263
Gurbel, Paul A., Eliano P. Navarese, and Udaya S. Tantry. “The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy.Eur Heart J 40, no. 29 (August 1, 2019): 2441–43. https://doi.org/10.1093/eurheartj/ehz263.
Gurbel PA, Navarese EP, Tantry US. The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy. Eur Heart J. 2019 Aug 1;40(29):2441–3.
Gurbel, Paul A., et al. “The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy.Eur Heart J, vol. 40, no. 29, Aug. 2019, pp. 2441–43. Pubmed, doi:10.1093/eurheartj/ehz263.
Gurbel PA, Navarese EP, Tantry US. The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy. Eur Heart J. 2019 Aug 1;40(29):2441–2443.
Journal cover image

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

August 1, 2019

Volume

40

Issue

29

Start / End Page

2441 / 2443

Location

England

Related Subject Headings

  • Ticagrelor
  • Myocardial Infarction
  • Humans
  • Fibrinolytic Agents
  • Coronary Artery Bypass
  • Cardiovascular System & Hematology
  • Aspirin
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences